Introduction - Uppsala Monitoring Centre

M.D. London, 1784. Based on information from English Short Title Catalogue. Eighteenth Century Collections Online. Gale
Group. http://0-galenet.galegroup.com.libsys.wellcome.ac.uk/servlet/ECCO
Sydenham Thomas. The whole works of that excellent practical physician Dr. Thomas Sydenham wherein not only the history
and cures of acute diseases are treated of, after a new and accurate method: but also the shortest and safest way of curing
most chronical diseases/translated from the Latin by John Pechy, London 1696
Tainter ML, Cutting WC and Stockton AB. Use of dinitrophenol in nutritional disorders: A critical survey of clinical results. Am J
Public Health Nations Health 1934 October; 24(10): 1045–1053.
Talbot CH. Some notes on Anglo-Saxon medicine. Med Hist 1965; 992);156–169
Taylor JM. Early botanists and the introduction of drug specifics. Bull NY Acad Med 1979; 55(7): 684-699.
Temple RJ. The clinical pharmacologist in drug regulation: the US perspective. Br J Clin Pharmacol 1996: 42: 73–79.
The History of Taxonomy 1583–1690 http://www.bihrmann.com/caudiciforms/DIV/ Accessed 25th February 2008.
The James Lind Library, which was created by The Library and Information Services Department of the Royal College of
Physicians of Edinburgh.
The Project Gutenberg eBook, The Oldest Code of Laws in the World, by Hammurabi, King of Babylon, Translated by CHW
Johns.
The Southwest School of Botanical Medicine http://www.swsbm.com/homepage/. Accessed 25th February 2008.
Thiselton-Dyer TF. The Folklore of Plants, Llanerch Publishers, Lampeter 1994; p315.
Thompson CJS. Mystery and Art of the Apothecary. Kessinger Publishing, 2003.
Thomson S, Steele JC and Reid G. A Dictionary of Domestic Medicine and Household Surgery. Charles Griffin & company.
1896.
Tibi Selma. The Medicinal Use of opium in Ninth-Century Baghdad. Brill, Sir Henry Wellcome Asian Series. 2006.
Tibi Selma. Al-Razi and Islamic medicine in the 9th century. J R Soc Med 2006; 99: 206–7.
Tognoni G, Begher C, Colombo F, Inzalaco M, Mancia M and Masera G. Present limitations and future possibilities of drug
surveillance in Italy. In Drug Induced Suffering. Excerpta Medica. Ed. T Soda. 1980.
Tomatis L. Experimental chemical carcinogenesis: Fundamental and predictive role in protecting health in the 1930s–1970s.
Eur J Oncol 2006; 11(1): 5–1.
Tröhler U. Quantification in British Medicine and Surgery 1750-1830, with special Reference to its Introduction into
Therapeutics. PhD thesis University of London. 1978.
Tröhler U. The introduction of numerical methods to assess the effects of medical intervention during the eighteenth century: a
brief history JR Soc Med 2011; 104:465-474.
Tsubaki T, Toyokura Y and Tsukagoshi H. Subacute myelo-optic-neuropathy following abdominal symptoms. Jpn J Med
1965; 4(3): 181–4.
Tyson TL. Agranulocytosis following pyrithyldione (Presidon) therapy. JAMA September 10th 1949;141(2):128.
Unschuld P. Medicine in China, a history of pharmaceutics. University of California Press, 1986.
Unschuld P. Chinese medicine. Paradigm Publications, Massachusetts, 1998.
Unschuld P. Forgotten tradition of ancient Chinese medicine; a Chinese view from the 18th century. The I-hsüeh Yüan Liu Lun
of 1757 by Hsü Ta-Ch’un. Paradigm Publications 1998.
Van Hoof H. Notes pour une histoire de la traduction pharmaceutique. Meta: Translators’ Journal 2001; vol. 46, n° 1, :154-17
Van Swearingen P. Placidyl and pulmonary odema. Ann Inter Med 1976; 84: 614–15.
Van-der-Linden-F-P. Detrimental effects of tetracycline on the formation of the deciduous and permanent teeth. Ned Tijdschr
Geneeskd 1965 Oct 9; 109(41): 1909–10.
Vane JR, Botting RM. Aspirin and other salicylates. London: Chapman and Hall Medical Publishers; 1992.
Vanherweghem J-L and Even-Adin D. Epidemiology of analgesic nephropathy in Belgium. Clin Nephrology 1982; 17(3): 129–
133.
Venning G. Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since
thalidomide. BMJ 1983:286: 199–202.
Venning G. Identification of adverse reactions to new drugs. II (continued): How were the important adverse reactions to new
drugs discovered and with what delays? BMJ 1983 286; 365–368.
Venning G. Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems. BMJ 1983;
286: 458–460.
Venning G. Identification of adverse reactions to new drugs. IV: Verification of suspected adverse reactions. BMJ 1983; 286:
544–547.
Venning G. Aplastic anaemia due to phenylbutazone. BMJ 1957; 2(5037): 146.